Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression

Keyphrases

• DNA Damage 100%
• Prostate Cancer Cells 100%
• Cancer Cells 100%
• Cisplatin Sensitivity 100%
• Budding Yeast 100%
• Phase Progression 100%
• Nitrogen mustard 100%
• Molecular Mechanism 50%
• Flow Cytometry 50%
• Human Carcinoma Cells 50%
• Cellular Sensitivity 50%
• Enhanced Sensitivity 50%
• Cisplatin Resistance 50%
• Cisplatin 50%
• Protease Inhibitors 50%
• Cancer Cell Lines 50%
• Sigma Phase 50%
• Ovarian Cancer Cells 50%
• Proteasomal Degradation 50%
• Related Compounds 50%
• Yeast Cells 50%
• Cell Cycle Progression 50%
• Life Cycle Analysis 50%
• Phosphatase 50%
• Colony Formation Assay 50%
• Phosphatase Inhibitors 50%
• Phase Delay 50%
• Transplatin 50%
• Checkpoint Arrest 50%
• MTS Assay 50%
• Platinum Agents 50%
• DNA Translesion Synthesis 50%
• Load Damage 50%
• Human Ovarian Cancer 50%
• Yeast Screening 50%

Biochemistry, Genetics and Molecular Biology

• Cancer Cell 100%
• Cisplatin 100%
• S Phase 100%
• Budding Yeast 100%
• Phosphatase 50%
• Chlormethine 50%
• Nitrogen Mustard 50%
• DNA Damage 25%
• Flow Cytometry 25%
• Proteasome 25%
• Cell Cycle Progression 25%
• Colony Formation 25%
• Cell-Cycle Analysis 25%

Immunology and Microbiology

• Cancer Cell 100%
• Budding Yeast 100%
• Cell Cycle 25%
• DNA Damage 25%
• Proteasome 25%
• Carcinoma Cell 25%
• Yeast Cell 25%
• Cell Cycle Progression 25%
• Colony Formation 25%